Glossary of medical terms: A B C D E F G H I J K L M N O P Q R S T U W V Y Z
Home » Medical Dictionary
 

  Barker, Horace Albert

Medical Dictionary

(1907-2000) American biochemist who, among other things, discovered the biologically active forms of vitamin B12.
Horace Albert Barker, informally called "Nook," was educated at Stanford University and earned a PhD in chemistry in 1933. His research interest then turned to soil microbiology and microbial biochemistry. He set out on a two-year postdoctoral fellowship to study first with C. B. van Niel at the Hopkins Marine Station, Pacific Grove, California, and then a year in the Netherlands to study with van Niel`s mentor, A. J. Kluyver in Delft. There he initiated an investigation that would later lead him to discover vitamin B12 coenzyme. Coenzymes are non-protein molecule that help the catalytic function of enzymes.

In 1936 Barker started his academic career at the University of California, Berkeley. Barker made major contributions to the study of bacterial metabolism, particularly in the synthesis and oxidation of fatty acids, the fermentation of amino acids and purines, and carbohydrate transformations. He was also well known for his pioneering use of radioactive carbon-14 tracers in biochemical research in the mid 1940s and for his work on the biochemical function of vitamin B12 in the late 1950s. In 1958 Barker discovered the biologically active forms (coenzyme forms) of B12 vitamins while working on the anaerobic metabolism of glutamate. Barker was also influential as a teacher and a mentor. As a student in his laboratory once wrote: "He teaches the course the way everyone imagines their favorite grandfather would do it."

Latest Medical News

» U.S. Food And Drug Administration Approves Pfizer’s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
» Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
» FDA approves Inlyta to treat patients with a type of advanced kidney cancer
» FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
» FDA. New and Generic Drug Approvals - January 27, 2012
» FDA. New and Generic Drug Approvals - January 26, 2012
» FDA. New and Generic Drug Approvals - January 25, 2012

Latest Medical Articles

» Wrist Injuries and Disorders
» West Nile Virus
» Wegener`s Granulomatosis
» Vulvar Disorders
» Vulvar Cancer
» Vitiligo
» Von Hippel-Lindau Disease
 

Latest Drugs

» Efavirenz Teva
» Desloratadine Actavis
» Repaglinide Accord
» Emselex
» Hepsera
» Zulvac 1 Ovis
» Zulvac 1 Bovis
 

Random terms - Medical Dictionary

Dientamoebiasis, dl-APV, Dracunculoses, Electrical Catheter Ablation, Embryoscopic Surgical Procedures, Epiphyseal Cartilages, Esterase 17, Ethyl Parathion, Etidronate, Event, Solar Particle, Extrachromosomal Inheritance, Fluorine 18 fluorodeoxyglucose, G-Protein, Stimulatory Gs, Goat Diseases, Heroin, HMG CoA Reductases, NAD-Dependent, jun B Proteins, jun Proto-Oncogene Proteins, Leucine Aryl Amidase, Leukemias, Mediastinoscopy, Meningococcal Hemorrhagic Adrenalitides, Mobility Assays, Supershift, Myogenic Regulatory Factors, Neutral Protease, Calcium-Activated, Organic Tremor Dysphonia, Parish Register, Peroneal Neuropathies, Deep, Plasma Membrane, Post Traumatic Headache, Presynaptic Receptor, Pulpitis, Radium, Ramipril, Reflux, Duodenal, Sex Dimorphism, Sexually Transmitted Diseases, Bacterial, Solutions, Hypertonic Glucose, Syndromes, Tumor Lysis, Tubal Ligation,

General Search


Last medical tags:


Torisel, temsirolimus, Inlyta, chronic myeloid leukemia, bosutinib, Inlyta, renal cell carcinoma, kidney cancer, myelin, Tysabri, natalizumab, brain infection, progressive multifocal leukoencephalopathy, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, thoracic aortic transection, endovascular graft, methotrexate, Voraxaze, cancer chemotherapy drug, glucarpidase, Adcetris, bleomycin, multifocal leukoencephalopathy, CardioGen-82, radiation, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, raltegravir, Isentress, antiretroviral medicines, Theravance, Relovair, asthma, fluticasone, bronchitis, neuromuscular disease, SMA, muscle atrophy, Resolor, prokinetic, prucalopride, ADHD, psychiatric behavioural disorder, Venvanse, lisdexamfetamine dimesylate, type 2 diabetes mellitus, Actoplus Met XR, pioglitazone, Mylan, Eprosartan Mesylate Tablets, Teveten, antimicrobials, cephapirin, cephalosporin, teriflunomide, Rebif, alanine aminotransferase levels, flu-like symptoms, multiple sclerosis, electrical pulses, implantable pulse generator, Precision Plus Spinal Cord Stimulator, genetic blood clotting disorder, hemophilia A, Advate, bleeding episodes, heart failure, heart transplantation, Pediatric Medical Device Safety, pulsatile cardiac assist device, selective serotonin reuptake inhibitor, SSRI, pulmonary hypertension,
» All tags  
Sitemap